Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 610

    1.

    High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.

    Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Schleicher E, Fritsche A, Häring HU.

    Diabetes Care. 2007 May;30(5):1173-8. Epub 2007 Jan 26.PMID: 17259477 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes.

    Jia W, Wu H, Bao Y, Wang C, Lu J, Zhu J, Xiang K.

    J Clin Endocrinol Metab. 2007 Aug;92(8):3224-9. Epub 2007 Jun 5.PMID: 17550959 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes.

    Gavi S, Stuart LM, Kelly P, Melendez MM, Mynarcik DC, Gelato MC, McNurlan MA.

    J Clin Endocrinol Metab. 2007 May;92(5):1886-90. Epub 2007 Feb 13.PMID: 17299074 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.

    Chavez AO, Coletta DK, Kamath S, Cromack DT, Monroy A, Folli F, DeFronzo RA, Tripathy D.

    Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E758-64. Epub 2009 Feb 3.PMID: 19190263 [PubMed - indexed for MEDLINE]Related articles

    5.

    Retinol-binding protein 4 in twins: regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action.

    Ribel-Madsen R, Friedrichsen M, Vaag A, Poulsen P.

    Diabetes. 2009 Jan;58(1):54-60. Epub 2008 Oct 13.PMID: 18852328 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Retinol-binding protein 4 expression in visceral and subcutaneous fat in human obesity.

    Bajzová M, Kováciková M, Vítková M, Klimcáková E, Polák J, Kovácová Z, Viguerie N, Vedral T, Mikulásek L, Srámková P, Srp A, Hejnová J, Langin D, Stich V.

    Physiol Res. 2008;57(6):927-34. Epub 2007 Nov 30.PMID: 18052678 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass.

    Klöting N, Graham TE, Berndt J, Kralisch S, Kovacs P, Wason CJ, Fasshauer M, Schön MR, Stumvoll M, Blüher M, Kahn BB.

    Cell Metab. 2007 Jul;6(1):79-87.PMID: 17618858 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression.

    Kovacs P, Geyer M, Berndt J, Klöting N, Graham TE, Böttcher Y, Enigk B, Tönjes A, Schleinitz D, Schön MR, Kahn BB, Blüher M, Stumvoll M.

    Diabetes. 2007 Dec;56(12):3095-100. Epub 2007 Aug 29.PMID: 17728376 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4.

    Yagmur E, Weiskirchen R, Gressner AM, Trautwein C, Tacke F.

    Diabetes Care. 2007 May;30(5):1168-72. Epub 2007 Mar 2.PMID: 17337499 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.

    Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ 3rd, Rashidi AA, McGehee RE Jr, Fried SK, Kern PA.

    J Clin Endocrinol Metab. 2007 Jul;92(7):2590-7. Epub 2007 Jun 26.PMID: 17595259 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.

    Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB.

    N Engl J Med. 2006 Jun 15;354(24):2552-63.PMID: 16775236 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition.

    Barber TM, Hazell M, Christodoulides C, Golding SJ, Alvey C, Burling K, Vidal-Puig A, Groome NP, Wass JA, Franks S, McCarthy MI.

    J Clin Endocrinol Metab. 2008 Jul;93(7):2859-65. Epub 2008 Apr 29.PMID: 18445670 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

    Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kröber SM, Machicao F, Fritsche A, Häring HU.

    Diabetes Care. 2006 Apr;29(4):853-7.PMID: 16567827 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.

    Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, Mandarino LJ, DeFronzo RA.

    J Clin Endocrinol Metab. 2002 Jun;87(6):2784-91.PMID: 12050251 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome.

    Weiping L, Qingfeng C, Shikun M, Xiurong L, Hua Q, Xiaoshu B, Suhua Z, Qifu L.

    Endocrine. 2006 Dec;30(3):283-7.PMID: 17526940 [PubMed - indexed for MEDLINE]Related articles

    16.

    Abdominal visceral fat reduction is associated with favorable changes of serum retinol binding protein-4 in nondiabetic subjects.

    Lee JW, Lee HR, Shim JY, Im JA, Lee DC.

    Endocr J. 2008 Oct;55(5):811-8. Epub 2008 May 21.PMID: 18493106 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis.

    Bahr MJ, Boeker KH, Manns MP, Tietge UJ.

    Clin Endocrinol (Oxf). 2009 Jan;70(1):60-5. Epub 2008 May 8.PMID: 18466349 [PubMed - indexed for MEDLINE]Related articles

    18.

    Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.

    Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, Lee HK, Park KS.

    Diabetes Care. 2006 Nov;29(11):2457-61.PMID: 17065684 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism.

    Hahn S, Backhaus M, Broecker-Preuss M, Tan S, Dietz T, Kimmig R, Schmidt M, Mann K, Janssen OE.

    Eur J Endocrinol. 2007 Aug;157(2):201-7.PMID: 17656599 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity.

    Vitkova M, Klimcakova E, Kovacikova M, Valle C, Moro C, Polak J, Hanacek J, Capel F, Viguerie N, Richterova B, Bajzova M, Hejnova J, Stich V, Langin D.

    J Clin Endocrinol Metab. 2007 Jun;92(6):2330-5. Epub 2007 Apr 3.PMID: 17405846 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data